# DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial

Study · id `cardio:ct-nct05305482` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05305482](<https://clinicaltrials.gov/study/NCT05305482>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05305482

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3520 participants.

## Technical summary

Registry record NCT05305482. Randomized; single masking; primary purpose treatment. Start 2022-08-10 (actual); primary completion 2030-02-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3520 participants (planned count; ClinicalTrials.gov record NCT05305482, source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)
- Started: 2022-08-10 (actual) (ClinicalTrials.gov record NCT05305482, source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)
- Primary completion: 2030-02-14 (anticipated) (ClinicalTrials.gov record NCT05305482, source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)
- Completion: 2030-02-14 (anticipated) (ClinicalTrials.gov record NCT05305482, source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT05305482, source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05305482-2025-05-21`, retrieved 2026-10-31)

## The registry's words

- Brief title: DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
- Acronym: ONE-PASS
- Condition: Acute Coronary Syndrome
- Intervention (Device): Drug-coated stent
- Intervention (Device): Drug-eluting stent
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: 3b4818d38e50396046bb34d459a2bf9114b1dc6bb841ddb775372c3328363a2e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
